Ciwujia Capsules/Compound Ciwujia Granules

PreclinicalSmall molecule

Ciwujia Capsules/Compound Ciwujia Granules is one of 38 small molecule programs targeting Insomnia. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

InsomniaActive, not recruiting

InsomniaPreclinical

Active, not recruiting

Competition

Competitive Landscape

153 competitors in Insomnia

#DrugCompanyPhaseTrials

Epidiolex

Jazz Pharmaceuticals

Phase 3

2 2

Elavil

AstraZeneca

Phase 3

1 3

Neurontin

VViatris Specialty LLC

Phase 3

7 4

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Phase 3

3 5

Hetlioz

VVanda Pharmaceuticals

Phase 3

2 6

Gaboxadol

Lundbeck

Phase 3

8 7

Volinanserin

Sanofi

Phase 3

2 8

Prosom

AAbbott

Phase 3

4 9

Org 50081

Merck & Co.

Phase 3

1 10

Nitrazepam

Astellas

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q2 2028

Not yet recruiting

Insomnia

NCT07286838

Clinical

Trials by Indication[1]

Insomnia1 trial

Ciwujia Capsules/Compound Ciwujia Granules in the Treatment of Insomnia

Not yet recruiting·HHui Zhu··NCT07286838·40,000 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Ciwujia Capsules/Compound Ciwujia Granules. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Ciwujia Capsules/Compound Ciwujia Granules compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Ciwujia Capsules/Compound Ciwujia Granules. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Hui Zhu company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: HHui Zhu

Ciwujia Capsules/Compound Ciwujia Granules

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q2 2028

Trials by Indication[1]

Insomnia1 trial

References

Drug Info

Quick Facts

Related News